Procurement scope (description)
The record description centers on developing a quantitative in vitro/in vivo extrapolation framework for predicting bioavailability effects across formulation, digestion, chylomicron binding, and prandial state.
Federal award
Award ID 75F40126C00063 | Action date Sep 26, 2026 | NAICS 541714 | PSC AN21
Department of Health and Human Services recorded a $575,554 definitive contract to Simulations Plus Inc on Sep 26, 2026. The source record describes the award as "THE OVERARCHING OBJECTIVE IS TO ESTABLISH A QUANTITATIVE IN VITRO IN VIVO EXTRAPOLATION FRAMEWORK CAPABLE OF PREDICTING THE INFLUENCE OF FORMULATION COMPOSITION, DIGESTION BEHAVIOR, CHYLOMICRON BINDING, AND PRANDIAL STATE ON DRUG BIOAVAILABILITY AND". GovSpendTrail links this record to its public USAspending.gov record for verification.
HHS awarded a definitive contract to Simulations Plus Inc for establishing a quantitative in vitro/in vivo extrapolation framework to assess drug bioavailability impacts from formulation composition, digestion behavior, chylomicron binding, and prandial state. The award action date is Sep 26, 2026, with current award amount of $575,554. NAICS 541714; PSC AN21. No linked subaward records are currently shown for this award.
The record description centers on developing a quantitative in vitro/in vivo extrapolation framework for predicting bioavailability effects across formulation, digestion, chylomicron binding, and prandial state.
Award type is DEFINITIVE CONTRACT. Action date is Sep 26, 2026. Current award amount is $575,554. Total obligation and period end date are not available in this record.
NAICS code is 541714 and PSC code is AN21, supporting classification of the contract’s work scope in the source record.
GovSpendTrail is independent and not a government website. Always verify records against the linked source system before business, legal, or compliance decisions.